Correction to: "Severe Hypertriglyceridemia in a Patient Treated With Sirolimus for Graft-vs-Host Disease Prophylaxis". [PDF]
europepmc +1 more source
Study protocol: Close Assessment and Testing for Chronic Graft-vs.-Host disease (CATCH). [PDF]
Pidala J +8 more
europepmc +1 more source
Cost-Effectiveness of Extracorporeal Photopheresis in Patients With Chronic Graft-vs-Host Disease. [PDF]
Peacock A +8 more
europepmc +1 more source
Outcomes of Importance to Patients Living With Cutaneous Chronic Graft-vs-Host Disease.
Baumrin E +9 more
europepmc +1 more source
The Impact of FDA-Approved Novel Agents for Steroid-Refractory Chronic Graft vs. Host Disease on Treatment Patterns and Outcomes-A Single-Center Longitudinal Cohort Analysis. [PDF]
Fridberg G +11 more
europepmc +1 more source
Ruxolitinib in steroid-refractory acute graft-vs-host disease: Japanese subgroup analysis of the randomized REACH2 trial. [PDF]
Teshima T +18 more
europepmc +1 more source
Umbilical Cord Blood Platelet Lysate Eyedrops for the Treatment of Severe Ocular Surface Disorders in Graft vs. Host Disease Patients: Clinical Study. [PDF]
Gagliano C +9 more
europepmc +1 more source
Autologous Gastrointestinal Graft-vs-Host Disease in a Patient With Multiple Myeloma and Hematopoietic Stem Cell Transplantation. [PDF]
Raza H, Naffouj S, Guzman G, Shuja A.
europepmc +1 more source
Graft-vs-Host Disease After Liver Transplantation: A Diagnostic and Management Challenge. [PDF]
Chin JY, Gong J, Gane E.
europepmc +1 more source

